1. Repository of OAI
Ελληνικά   English  

Browsing by Author Ninio, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 6 to 19 of 19 < previous 
TitleAuthor(s)Issue date???itemlist.???
Mechanisms of PAF formation upon copper-catalyzed oxidation of human LDLTsoukatos, D. C.; Liapikos, T. A.; Tselepis, A. D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidationAndroulakis, N.; Durand, H.; Ninio, E.; Tsoukatos, D. C.24-Nov-2015-
N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDLTselepis, A. D.; Karabina, S. A. P.; Stengel, D.; Piedagnel, R.; Chapman, M. J.; Ninio, E.24-Nov-2015-
PAF-acetylhydrolase is an antiinflammatory and antioxidant phospholipase A(2) that may be implicated in atherothrombosisTselepis, A. D.; Elisaf, M. S.; Goudevenos, J.; Karabina, S. A.; Tsoukatos, D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Paf-Degrading Acetylhydrolase Is Preferentially Associated with Dense Ldl and Vhdl-1 in Human Plasma - Catalytic Characteristics and Relation to the Monocyte-Derived EnzymeTselepis, A. D.; Dentan, C.; Karabina, S. A. P.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolaseDentan, C.; Tselepis, A. D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European AncestryCasas, J. P.; Ninio, E.; Panayiotou, A.; Palmen, J.; Cooper, J. A.; Ricketts, S. L.; Sofat, R.; Nicolaides, A. N.; Corsetti, J. P.; Fowkes, F. G.; Tzoulaki, I.; Kumari, M.; Brunner, E. J.; Kivimaki, M.; Marmot, M. G.; Hoffmann, M. M.; Winkler, K.; Marz, W.; Ye, S.; Stirnadel, H. A.; Boekholdt, S. M.; Khaw, K. T.; Humphries, S. E.; Sandhu, M. S.; Hingorani, A. D.; Talmud, P. J.24-Nov-2015-
Platelet-Activating Factor (Paf) Bioactivity Formation and Lyso-Paf Accumulation in Human ArteriesTsoukatos, D. C.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Brocheriou, I.; Ninio, E.; Sismanidis, S.; Siminelakis, S.24-Nov-2015-
Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary arteryTsoukatos, D. C.; Brocheriou, I.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Sismanidis, S.; Ninio, E.; Siminelakis, S.24-Nov-2015-
Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoproteinTsoukatos, D. C.; Liapikos, T. A.; Tselepis, A. D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Platelet-activating factor bio-system in human arteriesTsoukatos, D. C.; Brocheriou, I.; Ninio, E.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Sismanidis, S.; Siminelakis, S.24-Nov-2015-
Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplastyGoudevenos, J.; Tselepis, A. D.; Vini, M. P.; Michalis, L.; Tsoukatos, D. C.; Elisaf, M.; Ninio, E.; Sideris, D. A.24-Nov-2015-
The role of PAF-acetylhydrolase in the development of atherosclerosisTsoukatos, D. C.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussisis, S.; Brocheriou, I.; Ninio, E.; Sismanidis, S.; Siminelakis, S.24-Nov-2015-
Substantial contribution of C16 : 0 PAF on the PAF-like bioactivity formed in oxidized LDLAndroulakis, N.; Ninio, E.; Tsoukatos, D. C.24-Nov-2015-
Showing results 6 to 19 of 19 < previous